Boots and Microsoft tie up seven-year technology deal


Different institutions may use various terminologies for how they describe their ratings.

Walgreens Boots Alliance, Inc operates as a pharmacy-led health and wellbeing company. ValuEngine upgraded shares of Walgreens Boots Alliance from a "strong sell" rating to a "sell" rating in a report on Friday, September 21st. TheStreet raised Walgreens Boots Alliance from a c+ rating to a b rating in a report on Wednesday, September 12th. Three analysts have rated the stock with a sell rating, twelve have issued a hold rating and five have assigned a buy rating to the company's stock. Finally, SunTrust Banks boosted their target price on shares of Walgreens Boots Alliance to $75.00 and gave the company a "hold" rating in a research note on Friday, October 12th.

Shares of NASDAQ:WBA traded up $0.21 during trading on Friday, reaching $72.00. The volume amounted to 5944550 shares which compares with the average volume of 6.95M shares. On the other side the debt to equity ratio is 0.62. The firm has a market cap of $67.65 billion, a price-to-earnings ratio of 11.93, a PEG ratio of 1.12 and a beta of 0.99.

Following some earnings data for Lear Corporation (NYSE:LEA), we note that the current quarter EPS consensus estimate is 4.45. Walgreens Boots Alliance had a return on equity of 22.17% and a net margin of 3.96%. The quick ratio of 0.4 is a measure of how well a company can meet its short-term financial liabilities with quick assets (cash and cash equivalents, short-term marketable securities, and accounts receivable).

Another Major Winter Storm Is Expected Just Days After Gia
Sunday morning, the rain should briefly turn back into snow and a wintry mix before the storm moves out of the area. System number two won't reach the area until Saturday evening, but it will be packing a lot more moisture.

The 24 analysts offering 12-month price forecasts for Walgreens Boots Alliance Inc have a median target of 75.00, with a high estimate of 95.00 and a low estimate of 63.00. The shares were sold at an average price of $78.77, for a total value of $4,096,040.00. Investors, especially technical analysts, may use the 52 week range to gauge whether a stock's current price suggests buying, selling, or taking no-action. The stock was sold at an average price of $79.48, for a total transaction of $217,457.28.

EPS is the portion of a company's profit allocated to each exceptional share of common accretion. The disclosure for this sale can be found here. SMA 50 is an average stock price from the last 50 days calculated as an unweighted mean of the previous 50 stock closing prices. The correct version of this story can be viewed at The latest trading activity showed that the stock price is 21.58% off from its 52-week low and traded with move of -16.79% from high printed in the last 52-week period.

Intraday Trading of the Walgreens Boots Alliance, Inc.:Walgreens Boots Alliance, Inc. Cornerstone Advisors Inc. now owns 423 shares of the pharmacy operator's stock worth $31,000 after purchasing an additional 214 shares in the last quarter. The stock has shown a quarterly performance of -2.33% and a half-year performance stands at 10.17%. Asset Dedication LLC grew its position in shares of Walgreens Boots Alliance by 204.6% during the third quarter. Company insiders own 15.73% of the company's stock.

Stefano Pessina, executive vice chairman and CEO of Walgreens Boots Alliance, remarked: "We will work with Microsoft to harness the information that exists between payors and healthcare providers to leverage, in the interest of patients and with their consent, our extraordinary network of accessible and convenient locations to deliver new innovations, greater value and better health outcomes in health care systems across the world".